LEADERSHIP

We are on a mission to address the challenges that result from rapid changes in the science, technology and business of next-generation cancer care.

Trapelo Health Leadership

Clynt Taylor

President

Clynt Taylor is the President of Trapelo Health. He joined the company in 2017 and brings over 20 years of experience in healthcare technology innovation, both as an entrepreneur and senior executive with startup and growing companies.

 

Since beginning his career at IBM, he’s held leadership roles at healthcare technology companies like NextGen, where he led sales and marketing teams; HealthVision as General Manager of its fastest growing division (purchased by Lawson) and Galvanon as Co-founder and CEO Healthcare Solutions (purchased by NCR). Most recently, he held various senior executive roles with NantHealth – including leading the innovation, launch and commercialization of eviti, Inc., recognized today as one of the nation’s premier oncology decision support solutions. Clynt is married with four children and lives in the Dallas area.

Russ Ingersoll, PhD

Chief Product Officer

Russell Ingersoll joined Trapelo Health in 2010 bringing 15 years of healthcare information technology experience and proven success with the design and commercialization of information-based technology products for the clinical and life science industries.

 

Prior to joining Trapelo, Russ served as VP of Product Development for MedTrust Online, an oncology-centric information portal; Senior Director of Business Development at Phylogeny, Inc., a functional genomics services company; co-Founder of Folio Biosciences, a biobank of clinically annotated specimens and co-founder of BioProtocol, an interactive laboratory protocol system for the research community. Russ received a BS in Molecular and Cellular Biology from the University of Arizona, a PhD in Pharmacology and Toxicology from the University of Arizona College of Pharmacy and completed his post-doctoral training at the University of California, Berkeley.

Ephraim Hochberg, MD

Chairman, Editorial Board and Sr. Clinical Advisor

Dr. Hochberg serves as a Senior Clinical Advisor and Chairman of the Editorial Board of Trapelo Health. Dr. Hochberg received his MD from Case Western Reserve University School of Medicine, Ohio in 1996. He completed an internship and residency at Brigham and Women’s Hospital, followed by a fellowship at the Dana Farber Cancer Institute. Dr. Hochberg is an Assistant Professor of Medicine at Harvard Medical School and is an attending physician at the Massachusetts General Hospital. He serves as the Clinical Director of Inpatient Oncology at the Massachusetts General Hospital Cancer Center.

 

With over 50 peer-reviewed publications and book chapters, he directs his research efforts towards novel therapies for Hodgkin and non-Hodgkin lymphomas. Additionally, he is a member of the NCCN Guideline Panel for Hodgkin Lymphoma.

Janine_Morales_Headshot_Crop.png

Janine Morales, PhD

Chief Scientific Officer

Janine Morales joined Trapelo Health in 2011 and oversees a team of editors and curators with deep expertise in molecular oncology. Her group is responsible for maintaining the company’s comprehensive knowledge-base summarizing published data pertaining to molecular biomarkers as predictors of response to targeted therapies in oncology. Janine also led the development of the company's framework for the systematic evaluation and synthesis of molecular clinical evidence as well as the principles guiding the presentation of molecular evidence in patient specific reports.

 

She brings 15 years of editorial and information management experience in the biotech and medical sectors and was a member of research and development teams at Elan Corp. and DNAX Research Institute (acquired by Merck & Co). Janine received a BS in Biochemistry from the University of Rochester and earned her PhD in Pharmacology from the University of California, San Francisco.

Jerome_Madison_Corrected.png

E. Jerome Madison

VP Pharma + Provider Relations

In addition to being the host of the award-winning Precision Medicine Podcast, Jerome Madison leads provider relations and lab integration at Trapelo Health. Jerome is a 14-year veteran of the precision cancer movement who has led the most successful companies in the genomic testing space to become market leaders. He helped create best practices for market access and adoption of clinical genomics and bring his vast network and knowledge to Intervention Insights to develop the network of providers to launch Trapelo. In addition to leading start-ups and building people in the industry, Jerome is also a certified executive coach, a published author and keynote speaker on the topic of innovation.

Dean_Packer_01_5.png

Dean Packer

VP of Payer + Provider Strategy

Dean Packer brings over 25 years of experience in healthcare innovation to the Trapelo Health team, both as an executive with startup and Fortune 500 companies. 

 

Over his extensive career, Dean has held various sales and leadership roles at healthcare companies like NantHealth, Best Doctors, Anthem BCBS, Keystone Health Plan Central and several pharmaceutical companies. Most recently, Dean helped NantHealth launch GPS Cancer to payers – a new program in precision care management. Dean earned a BS in Biology from Bloomsburg University in Pennsylvania and currently lives in Southern York County. 

 

DSC_6028 copy ps-.jpg

Lisa Long, JD

Senior Director Provider Network

Lisa Long has a rich background in oncology diagnostics and pharmaceuticals. As the former director of Eviti's Channel Partnerships & Business Development at NantHealth, Lisa identified and created alliances with resellers including pharmacy benefit managers and healthcare IT leaders for the company’s oncology services. Additionally, her work with Eviti’s pre-authorization tool expanded her knowledge of payer and provider needs.

 

Previously, Lisa launched molecular diagnostic tests at NantHealth and sold oncology products for Bristol Myers-Squibb and Sanofi Oncology. She has worked continuously to develop a deep understanding of the challenges faced by both providers and patients throughout her travels in the oncology community. Lisa added a Juris Doctor of Law to her credentials with a concentration in health specifically focused on the FDA, public access to medical care and disability law.

Karan_Bio_original_02_Add.png

Karan Cushman

Head of Brand and Marketing

Karan Cushman joined Trapelo Health in 2016 and leads the company in developing a user-centered interface, strategic marketing program and strong brand equity for its innovative precision medicine platform, Trapelo. She is also the producer of The Precision Medicine Podcast. She is a marketing, design, and user-experience veteran who has spent more than 20 years immersed in the health, life science, and biomedical industries. Her award-winning work in these industries has been recognized globally for driving engagement, support, and brand loyalty. She is a certified IBM design-thinking facilitator, a graduate of Rochester Institute of Technology, and a cancer survivor.

Clinical + Scientific Advisory Panel

Ravi Salgia, MD, PhD, Panel Chairman
City of Hope National Medical Center

Paul A. Bunn, Jr., MD
University of Colorado Cancer Center

Ephraim Hochberg, MD
Mass General Hospital, Harvard Medical School

Guido Marcucci, MD

City of Hope National Medical Center

R. Steven Paulson, MD
Texas Oncology

Editorial Panel

Ephraim Hochberg, MD, Panel Chairman
Mass General Hospital, Harvard Medical School

Alice Shaw, MD, PhD
Mass General Hospital, Harvard Medical School

Aditya Bardia, MBBS, MPH
Mass General Hospital, Harvard Medical School

Wolfram Goessling, MD, PhD
Dana-Farber Cancer Institute, Harvard Medical School

Paul A. Bunn, Jr., MD
University of Colorado Cancer Center

Harriet M. Kluger, MD
Yale University Cancer Center

Anna F. Farago, MD, PhD
Mass General Hospital, Harvard Medical School

PMP_Logo_Trapelo_Trans_Final.png

Is collaboration the key to improving cancer patient outcomes?

In this episode, Trapelo Health President Clynt Taylor discusses how one healthcare technology is bringing oncology stakeholders together to ease the burdens of prior authorization and speed patient care.